The global market for Sleep Disorder Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Sleep disorders result in a lack of deep and restorative sleep.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Sleep Disorder Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleep Disorder Therapeutics.

The Sleep Disorder Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sleep Disorder Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sleep Disorder Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Sleep Disorder Therapeutics Market Report

Report Metric	Details
Report Name	Sleep Disorder Therapeutics Market
CAGR	5%
Segment by Type	Insomnia Excessive Sleep Disturbed Sleep
Segment by Application	Hospital Pharmacies Online Pharmacies Retail Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Sunovion Pharmaceuticals, Takeda Pharmaceutical, Somaxon Pharmaceuticals, Vanda Pharmaceuticals, Eli Lilly, GSK, Neurim Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sleep Disorder Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sleep Disorder Therapeutics Market report?

Ans: The main players in the Sleep Disorder Therapeutics Market are Sanofi, Sunovion Pharmaceuticals, Takeda Pharmaceutical, Somaxon Pharmaceuticals, Vanda Pharmaceuticals, Eli Lilly, GSK, Neurim Pharmaceuticals

What are the Application segmentation covered in the Sleep Disorder Therapeutics Market report?

Ans: The Applications covered in the Sleep Disorder Therapeutics Market report are Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

What are the Type segmentation covered in the Sleep Disorder Therapeutics Market report?

Ans: The Types covered in the Sleep Disorder Therapeutics Market report are Insomnia, Excessive Sleep, Disturbed Sleep

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sleep Disorder Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Insomnia

1.2.3 Excessive Sleep

1.2.4 Disturbed Sleep

1.3 Market by Application

1.3.1 Global Sleep Disorder Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Online Pharmacies

1.3.4 Retail Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sleep Disorder Therapeutics Market Perspective (2020-2031)

2.2 Global Sleep Disorder Therapeutics Growth Trends by Region

2.2.1 Global Sleep Disorder Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Sleep Disorder Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Sleep Disorder Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Sleep Disorder Therapeutics Market Dynamics

2.3.1 Sleep Disorder Therapeutics Industry Trends

2.3.2 Sleep Disorder Therapeutics Market Drivers

2.3.3 Sleep Disorder Therapeutics Market Challenges

2.3.4 Sleep Disorder Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sleep Disorder Therapeutics Players by Revenue

3.1.1 Global Top Sleep Disorder Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Sleep Disorder Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Sleep Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Sleep Disorder Therapeutics Revenue

3.4 Global Sleep Disorder Therapeutics Market Concentration Ratio

3.4.1 Global Sleep Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sleep Disorder Therapeutics Revenue in 2024

3.5 Global Key Players of Sleep Disorder Therapeutics Head office and Area Served

3.6 Global Key Players of Sleep Disorder Therapeutics, Product and Application

3.7 Global Key Players of Sleep Disorder Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Sleep Disorder Therapeutics Breakdown Data by Type

4.1 Global Sleep Disorder Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Type (2026-2031)

5 Sleep Disorder Therapeutics Breakdown Data by Application

5.1 Global Sleep Disorder Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Sleep Disorder Therapeutics Market Size (2020-2031)

6.2 North America Sleep Disorder Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Sleep Disorder Therapeutics Market Size by Country (2020-2025)

6.4 North America Sleep Disorder Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sleep Disorder Therapeutics Market Size (2020-2031)

7.2 Europe Sleep Disorder Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Sleep Disorder Therapeutics Market Size by Country (2020-2025)

7.4 Europe Sleep Disorder Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Sleep Disorder Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Sleep Disorder Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Sleep Disorder Therapeutics Market Size (2020-2031)

9.2 Latin America Sleep Disorder Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Sleep Disorder Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Sleep Disorder Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sleep Disorder Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Sleep Disorder Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Sleep Disorder Therapeutics Introduction

11.1.4 Sanofi Revenue in Sleep Disorder Therapeutics Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 Sunovion Pharmaceuticals

11.2.1 Sunovion Pharmaceuticals Company Details

11.2.2 Sunovion Pharmaceuticals Business Overview

11.2.3 Sunovion Pharmaceuticals Sleep Disorder Therapeutics Introduction

11.2.4 Sunovion Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025)

11.2.5 Sunovion Pharmaceuticals Recent Development

11.3 Takeda Pharmaceutical

11.3.1 Takeda Pharmaceutical Company Details

11.3.2 Takeda Pharmaceutical Business Overview

11.3.3 Takeda Pharmaceutical Sleep Disorder Therapeutics Introduction

11.3.4 Takeda Pharmaceutical Revenue in Sleep Disorder Therapeutics Business (2020-2025)

11.3.5 Takeda Pharmaceutical Recent Development

11.4 Somaxon Pharmaceuticals

11.4.1 Somaxon Pharmaceuticals Company Details

11.4.2 Somaxon Pharmaceuticals Business Overview

11.4.3 Somaxon Pharmaceuticals Sleep Disorder Therapeutics Introduction

11.4.4 Somaxon Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025)

11.4.5 Somaxon Pharmaceuticals Recent Development

11.5 Vanda Pharmaceuticals

11.5.1 Vanda Pharmaceuticals Company Details

11.5.2 Vanda Pharmaceuticals Business Overview

11.5.3 Vanda Pharmaceuticals Sleep Disorder Therapeutics Introduction

11.5.4 Vanda Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025)

11.5.5 Vanda Pharmaceuticals Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Details

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Sleep Disorder Therapeutics Introduction

11.6.4 Eli Lilly Revenue in Sleep Disorder Therapeutics Business (2020-2025)

11.6.5 Eli Lilly Recent Development

11.7 GSK

11.7.1 GSK Company Details

11.7.2 GSK Business Overview

11.7.3 GSK Sleep Disorder Therapeutics Introduction

11.7.4 GSK Revenue in Sleep Disorder Therapeutics Business (2020-2025)

11.7.5 GSK Recent Development

11.8 Neurim Pharmaceuticals

11.8.1 Neurim Pharmaceuticals Company Details

11.8.2 Neurim Pharmaceuticals Business Overview

11.8.3 Neurim Pharmaceuticals Sleep Disorder Therapeutics Introduction

11.8.4 Neurim Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025)

11.8.5 Neurim Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

Sunovion Pharmaceuticals

Takeda Pharmaceutical

Somaxon Pharmaceuticals

Vanda Pharmaceuticals

Eli Lilly

GSK

Neurim Pharmaceuticals

List of Tables

Table 1. Global Sleep Disorder Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Insomnia

Table 3. Key Players of Excessive Sleep

Table 4. Key Players of Disturbed Sleep

Table 5. Global Sleep Disorder Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Sleep Disorder Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Sleep Disorder Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Sleep Disorder Therapeutics Market Share by Region (2020-2025)

Table 9. Global Sleep Disorder Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Sleep Disorder Therapeutics Market Share by Region (2026-2031)

Table 11. Sleep Disorder Therapeutics Market Trends

Table 12. Sleep Disorder Therapeutics Market Drivers

Table 13. Sleep Disorder Therapeutics Market Challenges

Table 14. Sleep Disorder Therapeutics Market Restraints

Table 15. Global Sleep Disorder Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Sleep Disorder Therapeutics Market Share by Players (2020-2025)

Table 17. Global Top Sleep Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep Disorder Therapeutics as of 2024)

Table 18. Ranking of Global Top Sleep Disorder Therapeutics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Sleep Disorder Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Sleep Disorder Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Sleep Disorder Therapeutics, Product and Application

Table 22. Global Key Players of Sleep Disorder Therapeutics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Sleep Disorder Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Sleep Disorder Therapeutics Revenue Market Share by Type (2020-2025)

Table 26. Global Sleep Disorder Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Sleep Disorder Therapeutics Revenue Market Share by Type (2026-2031)

Table 28. Global Sleep Disorder Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Sleep Disorder Therapeutics Revenue Market Share by Application (2020-2025)

Table 30. Global Sleep Disorder Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Sleep Disorder Therapeutics Revenue Market Share by Application (2026-2031)

Table 32. North America Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Sleep Disorder Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Sleep Disorder Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Sleep Disorder Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Sleep Disorder Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Sleep Disorder Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Sleep Disorder Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Sleep Disorder Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Sanofi Company Details

Table 48. Sanofi Business Overview

Table 49. Sanofi Sleep Disorder Therapeutics Product

Table 50. Sanofi Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)

Table 51. Sanofi Recent Development

Table 52. Sunovion Pharmaceuticals Company Details

Table 53. Sunovion Pharmaceuticals Business Overview

Table 54. Sunovion Pharmaceuticals Sleep Disorder Therapeutics Product

Table 55. Sunovion Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)

Table 56. Sunovion Pharmaceuticals Recent Development

Table 57. Takeda Pharmaceutical Company Details

Table 58. Takeda Pharmaceutical Business Overview

Table 59. Takeda Pharmaceutical Sleep Disorder Therapeutics Product

Table 60. Takeda Pharmaceutical Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)

Table 61. Takeda Pharmaceutical Recent Development

Table 62. Somaxon Pharmaceuticals Company Details

Table 63. Somaxon Pharmaceuticals Business Overview

Table 64. Somaxon Pharmaceuticals Sleep Disorder Therapeutics Product

Table 65. Somaxon Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)

Table 66. Somaxon Pharmaceuticals Recent Development

Table 67. Vanda Pharmaceuticals Company Details

Table 68. Vanda Pharmaceuticals Business Overview

Table 69. Vanda Pharmaceuticals Sleep Disorder Therapeutics Product

Table 70. Vanda Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)

Table 71. Vanda Pharmaceuticals Recent Development

Table 72. Eli Lilly Company Details

Table 73. Eli Lilly Business Overview

Table 74. Eli Lilly Sleep Disorder Therapeutics Product

Table 75. Eli Lilly Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)

Table 76. Eli Lilly Recent Development

Table 77. GSK Company Details

Table 78. GSK Business Overview

Table 79. GSK Sleep Disorder Therapeutics Product

Table 80. GSK Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)

Table 81. GSK Recent Development

Table 82. Neurim Pharmaceuticals Company Details

Table 83. Neurim Pharmaceuticals Business Overview

Table 84. Neurim Pharmaceuticals Sleep Disorder Therapeutics Product

Table 85. Neurim Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)

Table 86. Neurim Pharmaceuticals Recent Development

Table 87. Research Programs/Design for This Report

Table 88. Key Data Information from Secondary Sources

Table 89. Key Data Information from Primary Sources

Table 90. Authors List of This Report

List of Figures

Figure 1. Sleep Disorder Therapeutics Picture

Figure 2. Global Sleep Disorder Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Sleep Disorder Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Insomnia Features

Figure 5. Excessive Sleep Features

Figure 6. Disturbed Sleep Features

Figure 7. Global Sleep Disorder Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Sleep Disorder Therapeutics Market Share by Application: 2024 VS 2031

Figure 9. Hospital Pharmacies Case Studies

Figure 10. Online Pharmacies Case Studies

Figure 11. Retail Pharmacies Case Studies

Figure 12. Sleep Disorder Therapeutics Report Years Considered

Figure 13. Global Sleep Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Sleep Disorder Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Sleep Disorder Therapeutics Market Share by Region: 2024 VS 2031

Figure 16. Global Sleep Disorder Therapeutics Market Share by Players in 2024

Figure 17. Global Top Sleep Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep Disorder Therapeutics as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Sleep Disorder Therapeutics Revenue in 2024

Figure 19. North America Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Sleep Disorder Therapeutics Market Share by Country (2020-2031)

Figure 21. United States Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Sleep Disorder Therapeutics Market Share by Country (2020-2031)

Figure 25. Germany Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Sleep Disorder Therapeutics Market Share by Region (2020-2031)

Figure 33. China Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Sleep Disorder Therapeutics Market Share by Country (2020-2031)

Figure 41. Mexico Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Sleep Disorder Therapeutics Market Share by Country (2020-2031)

Figure 45. Turkey Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Sanofi Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)

Figure 49. Sunovion Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)

Figure 50. Takeda Pharmaceutical Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)

Figure 51. Somaxon Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)

Figure 52. Vanda Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)

Figure 53. Eli Lilly Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)

Figure 54. GSK Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)

Figure 55. Neurim Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions